Report cover image

The Worldwide Market for Mass Spectrometry in Clinical Labs, 2024

Published Sep 12, 2024
Length 175 Pages
SKU # KLI19162418

Description

The Worldwide Market for Mass Spectrometry in Clinical Labs, 2024


Mass spectrometry (MS) is increasingly being integrated into clinical laboratories, revolutionizing diagnostics with its advanced sensitivity and specificity. This technology, once primarily utilized in research settings, is now making significant strides in clinical applications, particularly in areas like therapeutic drug monitoring, metabolite testing, steroid hormone analysis, and vitamin D testing. The growing demand for MS in clinical settings is driven by its ability to outperform traditional immunoassays in terms of accuracy and precision.

Kalorama Information’s The Worldwide Market for Mass Spectrometry in Clinical Labs, 2024 is a comprehensive market research report examines the global mass spectrometry market from 2023 to 2028, focusing on its expanding role in clinical diagnostics. It explores a wide range of applications, from microbial identification to proteomics and genomics, highlighting how MS technology is becoming disruptive in various areas of healthcare.

Key Highlights:
  • Market Analysis: The report provides an in-depth analysis of the global MS market, with a focus on the leading regions—North America, Japan, and Western Europe—which account for the majority of current MS instrument sales.
  • Clinical Applications: Detailed coverage of clinical MS applications, including therapeutic drug monitoring, vitamin D testing, neonatal screening, and more.
  • Market Data: Sales estimates for 2023 and projections through 2028, alongside revenue analysis of top MS competitors over the past three years.
  • Market Dynamics: Discussion of key drivers, challenges, and trends shaping the mass spectrometry market, as well as the broader impact of the global economy on clinical labs and MS markets.
  • Impact of FDA Ruling on Laboratory Developed Tests (LDTs): Mass spectrometer manufacturers must adapt to new FDA regulations regarding LDTs. This report takes into account this new development, with sales projections that reflect greater barriers to entry for new devices and new, albeit phased-in, oversight requirements for current products.
  • Company Profiles: Insights into companies developing or marketing MS platforms and products, focusing on those driving innovation in clinical settings.
This report is essential for stakeholders in the clinical laboratory and diagnostic industries, providing a comprehensive overview of the rapidly evolving mass spectrometry market and its potential to transform healthcare diagnostics.

Note: This report specifically focuses on human clinical applications of MS and does not delve into forensic, veterinary, or other non-clinical uses.

Table of Contents

175 Pages
    • Overview
    • Scope and Methodology
    • Market Overview
    • Future Prospects in the Mass Spectrometry Market
    • Brief History of Mass Spectrometry
    • Current Mass Spectrometry Technology
    • Mass Spectrometry Market Segments
    • Companies Marketing Mass Spectrometry Platforms and Related Products
    • Market Drivers
    • Market Challenges
    • Worldwide Mass Spectrometry Market
    • Competitive Analysis
    • Overview
    • LDT Services Market by Disease Segment
    • LDT Services Market by Geography
    • LDT Products and Reagents by Market Segment (PCR, Mass Spectrometry, NGS, Microarrays and Other)
    • Clinical Laboratory Testing
    • Current Economic Climate
    • 908 Devices, Inc.
    • Abbott Laboratories
    • Advion
    • Agena Bioscience
    • Agilent Technologies Inc.
    • Aliri Bioanalysis
    • Applied Proteomics, Inc.
    • Beckman Coulter, Inc.
    • Becton Dickinson
    • BGI
    • Biocrates Life Sciences, AG
    • Biodesix, Inc.
    • Biognosys AG
    • bioMérieux
    • Bio-Rad Laboratories
    • Bruker Corporation
    • Caprion Biosciences
    • Charles River Laboratories
    • Danaher Corporation
    • JEOL, Ltd.
    • Microsaic Systems plc
    • Mosaiques Diagnostics and Therapeutics AG
    • PerkinElmer, Inc.
    • Proteome Sciences plc
    • SCIEX Pte Ltd.
    • Sera Prognostics
    • Shimadzu Corp.
    • Standard BioTools
    • Thermo Fisher Scientific, Inc.
    • Waters Corporation
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.